• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asthma deaths in New Zealand: whodunnit?

作者信息

Blauw G J, Westendorp R G

机构信息

Department of Clinical Epidemiology, University Hospital Leiden, Netherlands.

出版信息

Lancet. 1995 Jan 7;345(8941):2-3. doi: 10.1016/s0140-6736(95)91143-x.

DOI:10.1016/s0140-6736(95)91143-x
PMID:7799701
Abstract
摘要

相似文献

1
Asthma deaths in New Zealand: whodunnit?
Lancet. 1995 Jan 7;345(8941):2-3. doi: 10.1016/s0140-6736(95)91143-x.
2
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
J Clin Epidemiol. 1997 Mar;50(3):321-8. doi: 10.1016/s0895-4356(96)00375-7.
3
Epidemiologic studies of beta agonists and asthma deaths.
Epidemiol Rev. 1998;20(2):173-86. doi: 10.1093/oxfordjournals.epirev.a017979.
4
Fenoterol and asthma mortality in New Zealand.
N Z Med J. 1990 Feb 28;103(884):73-5.
5
The use of beta agonists and the risk of death and near death from asthma.β受体激动剂的使用与哮喘导致的死亡及濒死风险。
J Clin Epidemiol. 2009 Jun;62(6):582-7. doi: 10.1016/j.jclinepi.2009.01.004.
6
Beta-agonist therapy and asthma mortality in Japan.
Lancet. 1998 May 9;351(9113):1406-7. doi: 10.1016/S0140-6736(05)79446-0.
7
Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.非诺特罗的停用与新西兰哮喘死亡率流行的终结。
Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7. doi: 10.1159/000237016.
8
Asthma and the beta agonist debate.哮喘与β受体激动剂之争
Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S5-10. doi: 10.1136/thx.50.suppl_1.s5.
9
End of the New Zealand asthma mortality epidemic.
Lancet. 1995 Jan 7;345(8941):41-4. doi: 10.1016/s0140-6736(95)91159-6.
10
The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Pediatrics. 1992 Oct;90(4):639-40.

引用本文的文献

1
Regular treatment with formoterol for chronic asthma: serious adverse events.福莫特罗用于慢性哮喘的常规治疗：严重不良事件
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006923. doi: 10.1002/14651858.CD006923.pub3.
2
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.福莫特罗常规治疗与沙美特罗常规治疗慢性哮喘的严重不良事件
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007695. doi: 10.1002/14651858.CD007695.pub3.
3
Current issues with beta2-adrenoceptor agonists: historical background.
β2肾上腺素能受体激动剂的当前问题：历史背景
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):107-18. doi: 10.1385/CRIAI:31:2:107.
4
Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years.希腊帕特雷市学童哮喘患病率：20年间的三项调查
Thorax. 2001 Jul;56(7):569-71. doi: 10.1136/thorax.56.7.569.
5
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.缺氧性哮喘患者吸入沙丁胺醇的心血管副作用
Thorax. 2001 Jul;56(7):567-9. doi: 10.1136/thorax.56.7.567.
6
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.使用长效β2受体激动剂患者的年龄和性别特异性哮喘死亡率：处方事件监测药物警戒研究
Drug Saf. 2001;24(6):475-81. doi: 10.2165/00002018-200124060-00005.
7
The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells.沙丁胺醇、倍氯米松和地塞米松对培养的气道平滑肌细胞纤连蛋白表达的影响。
Inflammation. 1999 Aug;23(4):321-31. doi: 10.1023/a:1020257532357.
8
beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man.β-肾上腺素能受体在人类低氧血症诱导的血管舒张中起作用。
Br J Clin Pharmacol. 1995 Nov;40(5):453-8.
9
Asthma and the beta agonist debate.哮喘与β受体激动剂之争
Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S5-10. doi: 10.1136/thx.50.suppl_1.s5.